Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.
Company profile
Website
CEO
Mark C. Trudeau
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Imcera Group Inc, Mallinckrodt Group Inc
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12B
Securities registration termination
14 Nov 00
8-K
Current report
25 Oct 00
S-3/A
Shelf registration (amended)
23 Oct 00
8-K
Current report
20 Sep 00
425
Business combination disclosure
18 Sep 00
10-K
2000 FY
Annual report
28 Aug 00
425
Business combination disclosure
22 Aug 00
8-K
Current report
10 Aug 00
8-K
Current report
10 Jul 00
425
Business combination disclosure
28 Jun 00
Latest ownership filings
11-K
Annual report of employee stock purchases
5 Jan 01
11-K
Annual report of employee stock purchases
17 Dec 99
11-K
Annual report of employee stock purchases
18 Dec 98
11-K
Annual report of employee stock purchases
19 Dec 97
11-K
Annual report of employee stock purchases
20 Dec 96
11-K
Annual report of employee stock purchases
22 Dec 95
11-K
Annual report of employee stock purchases
21 Dec 94